{"transactions":[{"id":793438,"issuer":{"id":4476,"kind":"organization","name":"Hemab Therapeutics Holdings, Inc.","symbol":"COAG"},"owners":[{"id":49866,"kind":"person","name":"Behrndt-Eriksen Mads Nikolaj","position":1,"cik":"0002128919","reported_name":"Behrndt-Eriksen Mads Nikolaj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:16:30.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":49016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 30, 2026. The shares underlying the option will vest over four years in equal monthly installments from May 1, 2026 through May 1, 2030."}],"balance_after":49016,"derivative":{"exercise_price":18,"expiration_date":"2036-04-29","underlying":"Common Stock","underlying_shares":49016},"source":{"system":"sec-edgar","filing":"0001193125-26-204033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2114044/000119312526204033/ownership.xml","form_type":"4"}},{"id":793437,"issuer":{"id":4476,"kind":"organization","name":"Hemab Therapeutics Holdings, Inc.","symbol":"COAG"},"owners":[{"id":49866,"kind":"person","name":"Behrndt-Eriksen Mads Nikolaj","position":1,"cik":"0002128919","reported_name":"Behrndt-Eriksen Mads Nikolaj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrants (Right to Buy)","published_at":"2026-05-04T20:16:30.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":195206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrant was granted on January 29, 2026. The shares underlying the warrant vest over four years, with 25% of the shares vesting on January 1, 2027 and the remaining shares vesting in equal monthly installments thereafter."}],"balance_after":195206,"derivative":{"exercise_price":6,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":195206},"source":{"system":"sec-edgar","filing":"0001193125-26-204033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2114044/000119312526204033/ownership.xml","form_type":"4"}}]}